These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12765547)

  • 1. Monitoring disappearance of monomers and generation of resistance to proteolysis during the formation of the activation domain of human procarboxypeptidase A2 (ADA2h) amyloid fibrils by matrix-assisted laser-desorption ionization-time-of-flight-MS.
    Villanueva J; Villegas V; Querol E; Avilés FX; Serrano L
    Biochem J; 2003 Sep; 374(Pt 2):489-95. PubMed ID: 12765547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein secondary structure and stability determined by combining exoproteolysis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Villanueva J; Villegas V; Querol E; Avilés FX; Serrano L
    J Mass Spectrom; 2002 Sep; 37(9):974-84. PubMed ID: 12271440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein engineering as a strategy to avoid formation of amyloid fibrils.
    Villegas V; Zurdo J; Filimonov VV; Avilés FX; Dobson CM; Serrano L
    Protein Sci; 2000 Sep; 9(9):1700-8. PubMed ID: 11045616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
    Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
    J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
    Lim A; Wally J; Walsh MT; Skinner M; Costello CE
    Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aggregation propensity and stability on amyloid fibril formation as studied by Fourier transform infrared spectroscopy and two-dimensional COS analysis.
    Cerdà-Costa N; De la Arada I; Avilés FX; Arrondo JL; Villegas S
    Biochemistry; 2009 Nov; 48(44):10582-90. PubMed ID: 19817500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of lactoferrin aggregation and amyloid formation.
    Nilsson MR; Dobson CM
    Biochemistry; 2003 Jan; 42(2):375-82. PubMed ID: 12525164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates.
    Cerdà-Costa N; Esteras-Chopo A; Avilés FX; Serrano L; Villegas V
    J Mol Biol; 2007 Mar; 366(4):1351-63. PubMed ID: 17204287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The palmitoyl groups of lung surfactant protein C reduce unfolding into a fibrillogenic intermediate.
    Gustafsson M; Griffiths WJ; Furusjö E; Johansson J
    J Mol Biol; 2001 Jul; 310(4):937-50. PubMed ID: 11453699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibril formation of hsp10 homologue proteins and determination of fibril core regions: differences in fibril core regions dependent on subtle differences in amino acid sequence.
    Yagi H; Sato A; Yoshida A; Hattori Y; Hara M; Shimamura J; Sakane I; Hongo K; Mizobata T; Kawata Y
    J Mol Biol; 2008 Apr; 377(5):1593-606. PubMed ID: 18329043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
    J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Toropygin IY; Kugaevskaya EV; Mirgorodskaya OA; Elisseeva YE; Kozmin YP; Popov IA; Nikolaev EN; Makarov AA; Kozin SA
    Rapid Commun Mass Spectrom; 2008; 22(2):231-9. PubMed ID: 18085519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic procarboxypeptidases: oligomeric structures and activation processes revisited.
    Ventura S; Gomis-Rüth FX; Puigserver A; Avilés FX; Vendrell J
    Biol Chem; 1997; 378(3-4):161-5. PubMed ID: 9165066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
    Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
    J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
    Bousset L; Redeker V; Decottignies P; Dubois S; Le Maréchal P; Melki R
    Biochemistry; 2004 May; 43(17):5022-32. PubMed ID: 15109261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein amyloidose misfolding: mechanisms, detection, and pathological implications.
    Jeyashekar NS; Sadana A; Vo-Dinh T
    Methods Mol Biol; 2005; 300():417-35. PubMed ID: 15657495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
    Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
    Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR solution structure of the activation domain of human procarboxypeptidase A2.
    Jiménez MA; Villegas V; Santoro J; Serrano L; Vendrell J; Avilés FX; Rico M
    Protein Sci; 2003 Feb; 12(2):296-305. PubMed ID: 12538893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.